Summary
In order to gain further knowledge about the potential role of catecholamines in mammary carcinoma, we have used the potent β-adrenergic antagonist cyanopindolol (CYP) as iodinated ligand to characterize β-adrenergic receptors in membranes prepared from mammary tumors induced by dimethylbenz(a)anthraene (DMBA) administration in the rat. The binding of [125I]CYP to membrane preparations of DMBA-induced rat mammary tumors is rapid at room temperature, reaching half maximal specific binding at 30 min of incubation. Scatchard analysis of the data indicates that [125I]CYP binds to a single class of high affinity sites (114 ± 2.1 fmoles/mg protein) at an apparent KD value of 38.0 ± 0.3 pM. The order of potency of a series of agonists to compete for [125I]CYP binding is consistent with interaction with a β2-subtype receptor: zinterol > (−)isoproterenol > (−)epinephrine» (−)norepinephrine. In addition, the potency of a series of specific β1, and β2 synthetic compounds to displace [125I]CYP in mammary tumors is similar to their potency in typical β2-adrenergic tissues. The binding of [125I]CYP to DMBA-induced rat mammary tumors shows a marked stereoselectivity, the (−)isomers of isoproterenol and propranolol being 150 and 80 times more potent, respectively, than their respective enantiomers. The autoradiographic localization of [125I]CYP performed on frozen sections revealed the presence of specific β-adrenergic receptors in all the malignant cells. Spontaneous mammary tumors of aging (18–22 months) female rats have high levels of β-adrenergic receptors. Castration decreased the concentration of [125I]CYP binding sites in DMBA-induced mammary tumors. A close correlation was observed between progressing, static, and regressing tumors after ovariectomy and β-adrenergic receptor concentration. The presence of β-adrenergic receptors in mammary tumors as well as the modulation of their level by ovarian hormones provides a mechanism for catecholaminergic influence in mammary cancer tissue.
Similar content being viewed by others
References
Williams LT, Lefkowitz RJ: Regulation of rabbit myometrial alpha-adrenergic receptors by estrogen and progesterone. J Clin Invest 60: 815–818, 1977
Krall JF, Mori H, Tuck ML, LeShon SL, Korenman SG: Demonstration of adrenergic catecholamines receptors in rat myometrium and their regulation by sex steroid hormones. Life Sci 23: 1073–1081, 1978
Jordan AW: Changes in ovarian β-adrenergic receptors during the estrous cycle of the rat. Biol Reprod 24: 245–248, 1981
Adashi EY, Hsueh AJW: Stimulation of β2-adrenergic receptor responsiveness by follicle-stimulating hormone in rat granulosa cellsin vitro andin vivo. Endocrinology 108: 2170–2178, 1981
Aguado LI, Petrovic SL, Ojeda SR: Ovarian β-adrenergic receptors during the onset of puberty: characterization, distribution and coupling to steroidogenic responses. Endocrinology 110: 1124–1132, 1982
Poyet P, Labrie F: Characterization of β-adrenergic receptors in dispersed rat Leydig cells. J Androl 8: 7–13, 1987
Poyet P, Labrie F: Characteristics of the β-adrenergic receptors in the rat ventral prostate using [125I]cyanopindolol. Mol Cell Endocrinol 48: 59–67, 1986
Wagner HR, Crutcher KA, Davis JN: Chronic estrogen treatment decreases β-adrenergic responses in rat cerebral cortex. Brain Res 171: 147–151, 1979
Vacas MI, Lowenstein PR, Cardinali DP: Testosterone decreases β-adreno-receptors in rat pineal gland and brain. J Neural Transm 53: 49–57, 1982
Petrovic SL, Stanic MA, Haugland RP, Dowben RM: Increased β-adrenergic complement in androgen-induced mouse kidney hypertrophy. Biochim Biophys Acta 676: 329–337, 1981
Colucci WS, Gimbrone Jr JA, Alexander RW: Estrogens, sympathectomy and catecholamines regulate the vascular alpha-adrenergic receptor. Clin Res 28: 162a (abstract), 1980
Roberts JM, Goldfien RD, Tsuschiya AM, Goldfien A, Insel PA: Estrogen treatment decreases alpha-adrenergic binding sites on rabbit platelets. Endocrinology 104: 722–728, 1979
Elliot JM, Peters JR, Grahame-Smith DG: Oestrogen and progesterone change the binding characteristic of alphaadrenergic and serotonin receptors on rabbit platelets. Eur J Pharmacol 66: 21–20, 1980
Loizzi RF, De Pont JH, Bonting SL: Inhibition by cyclic AMP of lactose production in lactating guinea pig mammary gland slices. Biochim Biophys Acta 392: 20–22, 1975
Plucinski TM, Baldwin RL: Effects of hormones on mammary adenosine 3′,5′-monophosphate levels and metabolism in normal and adrenalectomized lactating rats. Endocrinology 111: 2062–2065, 1982
Bar HP: Epinephrine- and prostaglandin-sensitive adenylate cyclase in mammary gland. Biochim Biophys Acta 321: 397–406, 1980
Sapag-Hagar M, Greenbaum AL: Adenose 3′,5′-monophosphate and hormone interrelationships in the mammary gland of the rat during pregnancy and lactation. Eur J Biochem 47: 303–312, 1974
Sapag-Hagar M, Greenbaum AL: Changes in the activities of adenylate cyclase and cAMP phosphodiesterase and the level of 3′,5′-cyclic adenosine monophosphate in rat mammary gland during pregnancy and lactation. Biochem Biophys Res Commun 58: 982–988, 1973
Bodwin YS, Hirayama PH, Regs YA, Cho-Chung YS: Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacological doses of 17β-estradiol: cyclic adenosine 3′,5′-monophosphate-mediated events. J Natl Cancer Inst 66: 321–326, 1981
Foecking MK, Abou-Issa H, Webb TE, Minton JP: Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors. J Natl Cancer Inst 71: 773–778, 1983
Ip C, Dao TL: Regulation of cyclic adenosine 3′,5′-monophosphate in relation to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats. Cancer Lett 8: 227–233, 1980
Lee C: Levels of cyclic nucleotides in autotransplanted 7,12-dimethyl-benz(a)anthracene-induced rat mammary tumors during their growth and regression. J Natl Cancer Inst 65: 1029–1032, 1980
Cho-Chung YS:In vivo inhibition of tumor growth by cyclic adenosine 3′,5′-monophosphate derivatives. Cancer Res 34: 3492–3496, 1974
Cho-Chung YS, Clair T, Shepheard C, Berghoffer B: Arrest of hormone-dependent mammary cancer growthin vivo andin vitro by cholera toxin. Cancer Res 43: 1473–1476, 1983
Klein DM, Loizzi RF: Enhancement of R333OAC rat mammary tumor growth and cellular differentiation by dibutyryl cyclic adenosine monophosphate. J Natl Cancer Inst 58: 813–818, 1977
Lavandero S, Donoso E, Sapag-Hagar M: β-adrenergic receptors in rat mammary gland. Biochem Pharmacol 34: 2034–2036, 1985
Asselin J, Kelly PA, Caron MG, Labrie F: Control of hormone receptor levels and growth of 7,12-dimethylbenz (a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology 101: 666–671, 1977
Meites J: Changes in neuroendocrine control of anterior pituitary function during aging. Neuroendocrinology 34: 151–156, 1982
Marchetti B, Cioni M: Opposite changes of pituitary and ovarian receptors for LHRH in ageing rats: further evidence for a direct neural control of ovarian LHRH receptor activity. Neuroendocrinology 48: 242–251, 1988
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin Phenol reagent. J Biol Chem 193: 265–275, 1951
Asselin J, Labrie F, Kelly PA, Philibert D, Raynaud JP: Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimenthylbenz(a)anthracene-induced mammary tumors and their hormonal control. Steroids 27: 395–404, 1976
Dubé D, Poyet P, Pelletier G, Labrie F: Radioautographic localization of β-adrenergic receptors in the rat ventral prostate. J Androl 7: 169–174, 1986
Rodbard D: Apparent positive cooperative effect in cyclic AMP and corticosterone production by related adrenal cells in response to ACTH analogs. Endocrinology 94: 1427–1437, 1974
Rodbard D, Lewald JE: Computer analysis of radioligand assay and radioimmunoassay data. In: Diczfalusy E (ed) Second Karolinska Symposium on Research Methods in Reproductive Endocrinology, Copenhagen. Bogtrykleriet Forum, 1970, pp 79–103
Cheng Y, Prusoff WH: Relationship between the inhibition constant (Ki) and the concentration of inhibitor which cause 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108, 1973
Scatchard G: The attractions of problems for small molecules and ions. Ann NY Acad Sci 51: 660–669, 1949
Kramer CY: Extension of multiple-range test to group means with unique numbers of replications. Biometrics 12: 307–310, 1956
Lands AM, Luduena FP, Buzzo HJ: Differentiation of receptors responsive to isoproterenol. Life Sci 6: 2241–2249, 1967
Lands AM, Arnold A, McAuliff JP, Luduena FP, Grown TG: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597–598, 1967
Dolphin A, Hamont M, Bockaert J: The resolution of dopamine and β1-and β2-adrenergic sensitive adenylate cyclase activities in homogenates of a cerebellum hippocampus and cerebral cortex. Brain Res 179: 305–317, 1979
Lacombe ML, Rene E, Guellaen G, Hanoune J: Transformation of the β2-adrenoreceptor in normal rat liver into a β1 type in Zajdela hepatoma. Nature 262: 70–73, 1976
Dunlop D, Shanks RG: Selective blockade of adrenoreceptive beta-receptors in the heart. Brit J Pharmacol 32: 201–218, 1968
Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37: 951–963, 1977
Huggins C, Briziarelli G, Sutton H: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 109: 25–42, 1959
Russo IH, Russo J: Developmental stage of the rat mammary gland as determinants of its susceptibility to 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 61: 1439–1449, 1978
McCarty R: Sympathetic-adrenal medullary and cardiovascular responses to acute cold stress in adult and aged rats. J Autonom Nerv Syst 12: 15–22, 1985
Sapolsky RM, Donnely T: Vulnerability to stresss-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 117: 662–665, 1985
Marchetti B, Spinola PG: Hormonal regulation of β-adrenergic receptor levels in rat normal mammary gland and mammary tumors induced by dimethylbenz(a)anthracene-(DMBA)-induced mammary tumor and the correlation with tumor growth (abst). Proc. of the 69th Endocrine Society Meeting, Indianapolis, no. 947, 1987, p 257
Marchetti B, Plante M, Poulin R, Labrie F: Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate. J Steroid Biochem 31: 411–419, 1988
Poyet G, Gagné B, Labrie F: Characteristics of the β-adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens. Prostate 9: 237–245, 1986
Marchetti B, Labrie F: Characteristics of Flutamide action on prostatic and testicular functions in the rat. J Steroid Biochem 29: 691–698, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marchetti, B., Spinola, P.G., Plante, M. et al. Beta-adrenergic receptors in DMBA-induced rat mammary tumors: Correlation with progesterone receptor and tumor growth. Breast Cancer Res Tr 13, 251–263 (1989). https://doi.org/10.1007/BF02106575
Issue Date:
DOI: https://doi.org/10.1007/BF02106575